Biologics for asthma and allergy.

  • Garry M. Walsh
  • Published 2017 in
    Current opinion in otolaryngology & head and neck…


PURPOSE OF REVIEW The development of monoclonal antibody-based biologics targeted at inhibition of the Th2 cytokines interleukin-4, interleukin-5 and interleukin-13 represent potentially effective treatments for asthma and allergic diseases. This short review is based on English-language original articles in PubMed or MedLine that reported significant… (More)
DOI: 10.1097/MOO.0000000000000352


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics